You are here

Integration of Buprenorphine into HIV Primary Care Settings: Tools from the Integrating HIV Innovative Practices Program

August 2012
Author: IHIP

HRSA HIV/AIDS Bureau (HAB)

This package of training and implementation tools was developed to assist Ryan White and other HIV clinics to integrate buprenorphine programs in primary care settings.

Training Manual

manual cover

Tool for HIV/AIDS clinical programs who are considering integrating opioid addiction treatment using buprenorphine. Chapters cover background and rationale, lessons learned from the HRSA SPNS Initiative, and information for prescribers and clinic managers.

Curriculum

This provides physicians the information needed to educate clinic staff and stakeholders on integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care. It also provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.

Webinar: Clinical Aspects of Buprenorphine Therapy

In this webinar clinicians provide a definition of buprenorphine. They describe how it works, what opioids do to the brain, and how buprenorphine differs from methadone. 

Also outlined are the following:

  • Important drug-drug interactions
  • The concept of precipitated withdrawal and how to recognize it
  • How to determine patient eligibility
  • Clinical aspects of working with opioid-addicted people living with HIV

Webinar: Training and Integration

This webinar introduced providers to the SPNS Buprenorphine Initiative, its findings, its synergy with the National HIV/AIDS Strategy, and provided an overview of opioid use and HIV.

FAQ and Peer Discussion

Find quick answers to common questions, or pose questions to the IHIP team.

Total views: 6,809
lifted